Evaluation of Dual Therapy in Real Life Setting in Treatment-Naive Turkish Patients with HCV Infection: A Multicenter, Retrospective Study

Date
2016
Author
Suer, Kaya
Tulek, Necla Eren
Tutuncu, Emin Ediz
Koruk, Suda Tekin
AYGEN, BİLGEHAN
DEMİRTÜRK, NEŞE
Kinikli, Sami
Kaya, Ali
Yildirmak, Taner
Korkmaz, Fatime
URAL, ONUR
AKHAN, SILA
GÜNAL, ÖZGÜR
Tuna, Nazan
Kose, Sukran
Gonen, Ibak
Batirel, Ayse
Tuncer, Gunay
Tosun, Dervis
ŞENER, ALPER
Aynioglu, Aynur
Altunok, Elif Sargin
Ormen, Bahar
Turker, Nesrin
Saltoglu, Nese
Bulut, Cemal
SIRMATEL, FATMA
Ulcay, Asim
Karagoz, Ergenekon
Gurbuz, Yunus
Metadata
Show full item record
Abstract
Background: Before the introduction of direct-acting antivirals in the treatment of chronic hepatitis C patients, the combination of peginterferon alpha and ribavirin was the standard therapy. Observational studies that investigated sustained virological response (SVR) rates by these drugs yielded different outcomes.
URI
http://hdl.handle.net/20.500.12627/145196
https://doi.org/10.5152/balkanmedj.2015.15859
Collections